# Gentex Corp: financial statements, quarterly

GNTX · Nasdaq · CIK 355811 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gntx.md) · [Financials](/companies/gntx/financials.md) · [Filings](/companies/gntx/filings.md) · [Insiders](/companies/gntx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gntx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [576](/filings/0000355811-25-000009.md) | [589](/filings/0000355811-25-000009.md) | [590](/filings/0000355811-25-000029.md) | [573](/filings/0000355811-25-000041.md) | [609](/filings/0000355811-25-000052.md) | [542](/filings/0000355811-25-000009.md) | [577](/filings/0000355811-26-000026.md) | [658](/filings/0000355811-26-000048.md) | [655](/filings/0000355811-25-000052.md) | [644 d](/filings/0000355811-26-000010.md) | [675](/filings/0000355811-26-000026.md) | [651](/filings/0000355811-26-000048.md) |
| Cost of revenue | $m | [384](/filings/0000355811-24-000048.md) | [386 d](/filings/0000355811-26-000010.md) | [388](/filings/0000355811-25-000029.md) | [384](/filings/0000355811-25-000041.md) | [404](/filings/0000355811-25-000052.md) | [365 d](/filings/0000355811-26-000010.md) | [385](/filings/0000355811-26-000026.md) | [433](/filings/0000355811-26-000048.md) | [430](/filings/0000355811-25-000052.md) | [420 d](/filings/0000355811-26-000010.md) | [447](/filings/0000355811-26-000026.md) | [410](/filings/0000355811-26-000048.md) |
| Gross profit | $m | [191](/filings/0000355811-25-000009.md) | [203](/filings/0000355811-25-000009.md) | [202](/filings/0000355811-25-000029.md) | [189](/filings/0000355811-25-000041.md) | [204](/filings/0000355811-25-000052.md) | [176](/filings/0000355811-25-000009.md) | [192](/filings/0000355811-26-000026.md) | [225](/filings/0000355811-26-000048.md) | [225](/filings/0000355811-25-000052.md) | [225 d](/filings/0000355811-26-000010.md) | [229](/filings/0000355811-26-000026.md) | [241](/filings/0000355811-26-000048.md) |
| Research and development | $m | [40.2](/filings/0000355811-24-000048.md) | [41.5 d](/filings/0000355811-26-000010.md) | [42.2](/filings/0000355811-25-000029.md) | [44.0](/filings/0000355811-25-000041.md) | [48.2](/filings/0000355811-25-000052.md) | [47.1 d](/filings/0000355811-26-000010.md) | [45.9](/filings/0000355811-26-000026.md) | [51.5](/filings/0000355811-26-000048.md) | [52.6](/filings/0000355811-25-000052.md) | [53.2 d](/filings/0000355811-26-000010.md) | [51.7](/filings/0000355811-26-000026.md) | [49.3](/filings/0000355811-26-000048.md) |
| Selling, general and administrative | $m | [28.8](/filings/0000355811-24-000048.md) | [29.1 d](/filings/0000355811-26-000010.md) | [30.7](/filings/0000355811-25-000029.md) | [29.7](/filings/0000355811-25-000041.md) | [30.1](/filings/0000355811-25-000052.md) | [30.5 d](/filings/0000355811-26-000010.md) | [29.9](/filings/0000355811-26-000026.md) | [48.5](/filings/0000355811-26-000048.md) | [49.7](/filings/0000355811-25-000052.md) | [49.7 d](/filings/0000355811-26-000010.md) | [49.8](/filings/0000355811-26-000026.md) | [50.0](/filings/0000355811-26-000048.md) |
| Operating income | $m | [122](/filings/0000355811-25-000009.md) | [133](/filings/0000355811-25-000009.md) | [129](/filings/0000355811-25-000029.md) | [115](/filings/0000355811-25-000041.md) | [126](/filings/0000355811-25-000052.md) | [89.8](/filings/0000355811-25-000009.md) | [113](/filings/0000355811-26-000026.md) | [119](/filings/0000355811-26-000048.md) | [122](/filings/0000355811-25-000052.md) | [120 d](/filings/0000355811-26-000010.md) | [124](/filings/0000355811-26-000026.md) | [141](/filings/0000355811-26-000048.md) |
| Income tax | $m | [19.8](/filings/0000355811-24-000048.md) | [19.0 d](/filings/0000355811-26-000010.md) | [19.4](/filings/0000355811-25-000029.md) | [15.3](/filings/0000355811-25-000041.md) | [22.9](/filings/0000355811-25-000052.md) | [10.1 d](/filings/0000355811-26-000010.md) | [18.8](/filings/0000355811-26-000026.md) | [19.8](/filings/0000355811-26-000048.md) | [19.7](/filings/0000355811-25-000052.md) | [18.1 d](/filings/0000355811-26-000010.md) | [19.6](/filings/0000355811-26-000026.md) | [22.6](/filings/0000355811-26-000048.md) |
| Net income | $m | [105](/filings/0000355811-24-000048.md) | [117](/filings/0000355811-24-000011.md) | [108](/filings/0000355811-24-000027.md) | [86.0](/filings/0000355811-25-000041.md) | [123](/filings/0000355811-25-000052.md) | [87.7](/filings/0000355811-25-000009.md) | [94.9](/filings/0000355811-26-000026.md) | [96.0](/filings/0000355811-26-000048.md) | [101](/filings/0000355811-25-000052.md) | [93.0 d](/filings/0000355811-26-000010.md) | [98.5](/filings/0000355811-26-000026.md) | [115](/filings/0000355811-26-000048.md) |
| Diluted EPS | $ per share | [0.45](/filings/0000355811-25-000009.md) | [0.50](/filings/0000355811-25-000009.md) | [0.47](/filings/0000355811-25-000029.md) | [0.37](/filings/0000355811-25-000041.md) | [0.53](/filings/0000355811-25-000052.md) | [0.39](/filings/0000355811-25-000009.md) | [0.42](/filings/0000355811-26-000026.md) | [0.43](/filings/0000355811-26-000048.md) | [0.46](/filings/0000355811-25-000052.md) | not reported | [0.46](/filings/0000355811-26-000026.md) | [0.54](/filings/0000355811-26-000048.md) |
| Basic EPS | $ per share | [0.45](/filings/0000355811-25-000009.md) | [0.50](/filings/0000355811-25-000009.md) | [0.47](/filings/0000355811-25-000029.md) | [0.37](/filings/0000355811-25-000041.md) | [0.54](/filings/0000355811-25-000052.md) | [0.39](/filings/0000355811-25-000009.md) | [0.42](/filings/0000355811-26-000026.md) | [0.43](/filings/0000355811-26-000048.md) | [0.46](/filings/0000355811-25-000052.md) | not reported | [0.46](/filings/0000355811-26-000026.md) | [0.54](/filings/0000355811-26-000048.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [261](/filings/0000355811-23-000056.md) | [226](/filings/0000355811-25-000009.md) | [249](/filings/0000355811-24-000027.md) | [260](/filings/0000355811-24-000038.md) | [180](/filings/0000355811-24-000048.md) | [233](/filings/0000355811-26-000010.md) | [287](/filings/0000355811-25-000029.md) | [120](/filings/0000355811-25-000041.md) | [179](/filings/0000355811-25-000052.md) | [146](/filings/0000355811-26-000048.md) | [165](/filings/0000355811-26-000026.md) | [233](/filings/0000355811-26-000048.md) |
| Current assets | $m | [1,055](/filings/0000355811-23-000056.md) | [998](/filings/0000355811-25-000009.md) | [1,073](/filings/0000355811-24-000027.md) | [1,084](/filings/0000355811-24-000038.md) | [1,046](/filings/0000355811-24-000048.md) | [1,037](/filings/0000355811-26-000010.md) | [1,089](/filings/0000355811-25-000029.md) | [1,062](/filings/0000355811-25-000041.md) | [1,168](/filings/0000355811-25-000052.md) | [1,128](/filings/0000355811-26-000048.md) | [1,208](/filings/0000355811-26-000026.md) | [1,231](/filings/0000355811-26-000048.md) |
| Total assets | $m | [2,558](/filings/0000355811-23-000056.md) | [2,611](/filings/0000355811-25-000009.md) | [2,713](/filings/0000355811-25-000029.md) | [2,738](/filings/0000355811-24-000038.md) | [2,735](/filings/0000355811-24-000048.md) | [2,761](/filings/0000355811-26-000010.md) | [2,783](/filings/0000355811-25-000029.md) | [2,814](/filings/0000355811-25-000041.md) | [2,939](/filings/0000355811-25-000052.md) | [2,929](/filings/0000355811-26-000048.md) | [2,998](/filings/0000355811-26-000026.md) | [2,999](/filings/0000355811-26-000048.md) |
| Current liabilities | $m | [274](/filings/0000355811-23-000056.md) | [272](/filings/0000355811-25-000009.md) | [304](/filings/0000355811-24-000027.md) | [305](/filings/0000355811-24-000038.md) | [283](/filings/0000355811-24-000048.md) | [253](/filings/0000355811-26-000010.md) | [267](/filings/0000355811-25-000029.md) | [337](/filings/0000355811-25-000041.md) | [394](/filings/0000355811-25-000052.md) | [388](/filings/0000355811-26-000048.md) | [445](/filings/0000355811-26-000026.md) | [405](/filings/0000355811-26-000048.md) |
| Total liabilities | $m | [290](/filings/0000355811-23-000056.md) | [299](/filings/0000355811-25-000009.md) | [337](/filings/0000355811-24-000027.md) | [338](/filings/0000355811-24-000038.md) | [318](/filings/0000355811-24-000048.md) | [289](/filings/0000355811-26-000010.md) | [303](/filings/0000355811-25-000029.md) | [381](/filings/0000355811-25-000041.md) | [441](/filings/0000355811-25-000052.md) | [438](/filings/0000355811-26-000048.md) | [492](/filings/0000355811-26-000026.md) | [458](/filings/0000355811-26-000048.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000355811-26-000010.md) | not reported | [3.9](/filings/0000355811-25-000041.md) | [4.1](/filings/0000355811-25-000052.md) | [3.8](/filings/0000355811-26-000048.md) | [3.8](/filings/0000355811-26-000026.md) | [3.7](/filings/0000355811-26-000048.md) |
| Shareholders' equity | $m | [2,268](/filings/0000355811-24-000048.md) | [2,313](/filings/0000355811-25-000009.md) | [2,376](/filings/0000355811-24-000038.md) | [2,400](/filings/0000355811-24-000048.md) | [2,418](/filings/0000355811-24-000048.md) | [2,468](/filings/0000355811-26-000010.md) | [2,475](/filings/0000355811-25-000029.md) | [2,430](/filings/0000355811-25-000041.md) | [2,495](/filings/0000355811-25-000052.md) | [2,488](/filings/0000355811-26-000026.md) | [2,503](/filings/0000355811-26-000026.md) | [2,538](/filings/0000355811-26-000048.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [126 d](/filings/0000355811-24-000048.md) | [170 d](/filings/0000355811-26-000010.md) | [130](/filings/0000355811-25-000029.md) | [129 d](/filings/0000355811-25-000041.md) | [84.7 d](/filings/0000355811-25-000052.md) | [154 d](/filings/0000355811-26-000010.md) | [149](/filings/0000355811-26-000026.md) | [166 d](/filings/0000355811-26-000048.md) | [147 d](/filings/0000355811-25-000052.md) | [125 d](/filings/0000355811-26-000010.md) | [137](/filings/0000355811-26-000026.md) | [185 d](/filings/0000355811-26-000048.md) |
| Capital expenditure | $m | [31.1 d](/filings/0000355811-24-000048.md) | [62.3 d](/filings/0000355811-26-000010.md) | [31.9](/filings/0000355811-25-000029.md) | [31.8 d](/filings/0000355811-25-000041.md) | [39.3 d](/filings/0000355811-25-000052.md) | [41.7 d](/filings/0000355811-26-000010.md) | [36.7](/filings/0000355811-26-000026.md) | [31.1 d](/filings/0000355811-26-000048.md) | [35.6 d](/filings/0000355811-25-000052.md) | [25.7 d](/filings/0000355811-26-000010.md) | [17.0](/filings/0000355811-26-000026.md) | [19.2 d](/filings/0000355811-26-000048.md) |
| Dividends paid | $m | [28.0 d](/filings/0000355811-24-000048.md) | [28.0 d](/filings/0000355811-26-000010.md) | [27.8](/filings/0000355811-25-000029.md) | [27.7 d](/filings/0000355811-25-000041.md) | [27.6 d](/filings/0000355811-25-000052.md) | [27.3 d](/filings/0000355811-26-000010.md) | [27.3](/filings/0000355811-26-000026.md) | [27.0 d](/filings/0000355811-26-000048.md) | [26.3 d](/filings/0000355811-25-000052.md) | [26.3 d](/filings/0000355811-26-000010.md) | [25.9](/filings/0000355811-26-000026.md) | [25.6 d](/filings/0000355811-26-000048.md) |
| Share repurchases | $m | [22.7 d](/filings/0000355811-24-000048.md) | [70.5 d](/filings/0000355811-26-000010.md) | [41.2](/filings/0000355811-25-000029.md) | [46.7 d](/filings/0000355811-25-000041.md) | [96.6 d](/filings/0000355811-25-000052.md) | [21.5 d](/filings/0000355811-26-000010.md) | [67.8](/filings/0000355811-26-000026.md) | [131 d](/filings/0000355811-26-000048.md) | [30.2 d](/filings/0000355811-25-000052.md) | [86.5 d](/filings/0000355811-26-000010.md) | [68.6](/filings/0000355811-26-000026.md) | [69.2 d](/filings/0000355811-26-000048.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [232](/filings/0000355811-23-000056.md) | [231](/filings/0000355811-24-000027.md) | [230](/filings/0000355811-24-000038.md) | [230](/filings/0000355811-24-000048.md) | [228](/filings/0000355811-25-000029.md) | [228](/filings/0000355811-25-000041.md) | [226](/filings/0000355811-25-000052.md) | [224](/filings/0000355811-26-000026.md) | [220](/filings/0000355811-26-000048.md) | [216](/filings/0000355811-25-000052.md) | [211](/filings/0000355811-26-000026.md) | [209](/filings/0000355811-26-000048.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 210,683,331 at 2026-07-24, from the cover of the [10-Q filed 2026-08-04](/filings/0000355811-26-000048.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.